Apple worsens selloff in beleaguered growth stocks

Apple worsens selloff in beleaguered growth stocks By Reuters

© Reuters. FILE PHOTO: Logo of an Apple store is in Washington, U.S., January 27, 2022. REUTERS/Joshua Roberts/File Photo/File Photo (Reuters) – Apple Inc (NASDAQ:) shares fell 4% in premarket trading on Wednesday and piled pressure on other growth stocks following a report that the tech giant was dropping its plans to boost production of the latest model of its...

Ignoring Yield Below 1% Is Your Biggest Mistake [Podcast]

High-Yield Stock Battle [Podcast] – The Dividend Guy Blog

Subscribe Finding quality stocks yielding over 5% is not that simple! Yet, many retirees or income-seeking investors are looking for them. We’ve decided to help them out with a stock battle! For each pick, Mike will discuss why he likes it and Vero will challenge him with another similar idea! Who wins? Let us know in the comments! Download the...

Nike (NYSE:NKE): Q1 Earnings Expected to Display a Mixed Bag

Nike (NYSE:NKE): Q1 Earnings Expected to Display a Mixed Bag

Athletic footwear, clothes, and accessory maker Nike, Inc. (NYSE:NKE) is set to release its first quarter Fiscal 2023 results on September 29, after the market closes. The Street expects Nike to post diluted earnings of $0.92 per share in Q1, significantly lower than its comparative prior year period’s figure of $1.16 per share. Meanwhile, revenue is pegged at $12.29 billion, almost...

Alzheimer's drug succeeds in slowing cognitive decline, makers Eisai and Biogen say

Alzheimer’s drug succeeds in slowing cognitive decline, makers Eisai and Biogen say By Reuters

2/2 © Reuters. An Alzheimer’s patient rests on a bench after a walk at the Village Landais Alzheimer site in Dax, France, September 24, 2020. Picture taken on September 24, 2020. REUTERS/Gonzalo Fuentes/File Photo 2/2 By Deena Beasley and Julie Steenhuysen (Reuters) -Eisai Co Ltd and Biogen Inc (NASDAQ:) on Tuesday said their experimental Alzheimer’s drug significantly slowed cognitive and...

Horton and Toll Brothers: These Homebuilder Stocks Could Benefit From the Housing Bubble

Horton and Toll Brothers: These Homebuilder Stocks Could Benefit From the Housing Bubble

The U.S. housing market is locked in a paradox of sorts. Homebuilders have too many unsold properties in hand now, but the U.S. is still suffering from a housing shortage. The only apparent way to bring an equilibrium is for homebuilders to turn inconveniences into opportunities during downturns. If this narrative is anything to go by, two stocks that will...

Porsche's blockbuster IPO is no 'gamechanger' for Europe's battered markets

Porsche’s blockbuster IPO is no ‘gamechanger’ for Europe’s battered markets By Reuters

© Reuters. FILE PHOTO: A logo of Porsche is seen outside a Porsche car dealer, amid the coronavirus disease (COVID-19) outbreak in Brussels, Belgium May 28, 2020. REUTERS/Yves Herman/ By Lucy Raitano and Andres Gonzalez LONDON (Reuters) – Porsche’s landmark listing is defying market turmoil giving a welcome boost to a battered pipeline of share sales but the deal is...

Procter & Gamble Stock Has Outperformed The S&P 500 Since 2017 End: Here's Why

Procter & Gamble Stock Has Outperformed The S&P 500 Since 2017 End: Here’s Why

Procter & Gamble (NYSE: PG) stock price gained almost 50% from around $92 at 2018 end to $135 currently, primarily due to favorable changes in its revenues and P/S multiple. Additionally, the company witnessed a steady rise in its revenue per share, helped by a drop in the outstanding share count. The stock’s gains have helped PG outperform the S&P,...

Facing talent shortage, Taiwanese chip test firm ASE boosts automation

Facing talent shortage, Taiwanese chip test firm ASE boosts automation By Reuters

© Reuters. FILE PHOTO: Semiconductor chips are seen on a circuit board of a computer in this illustration picture taken February 25, 2022. REUTERS/Florence Lo/Illustration By Sarah Wu TAIPEI (Reuters) – Taiwan’s ASE Technology Holding Co (NYSE:) Ltd, one of the world’s largest semiconductor testing and packaging firms, said on Wednesday that it would build a more advanced smart factory,...

2 "Strong Buy" Stocks Sparking Interest From Insiders

2 “Strong Buy” Stocks Sparking Interest From Insiders

Such has been the force of the cumulative headwinds in 2022 that trying to make headway in this year’s downtrending market has been a struggle for most. A slowing economy, decades-high inflation and the accompanying rate hikes in the attempt to tame it, not to mention Russia’s invasion of Ukraine and the impact on energy prices have all played their...

Japan's Shionogi says COVID pill reaches endpoint in Phase III trial

Japan’s Shionogi says COVID pill reaches endpoint in Phase III trial By Reuters

© Reuters. FILE PHOTO: Isao Teshirogi, President and CEO at Shionogi & Co Ltd, speaks during an interview with Reuters in Tokyo, Japan June 11, 2019. REUTERS/Issei Kato TOKYO (Reuters) – Japan’s Shionogi & Co Ltd said on Wednesday its oral treatment for COVID-19 demonstrated a significant reduction in symptoms compared to a placebo in a Phase III trial in...